Artificial Intelligence is making rapid strides in various fields. ChatGPT-maker OpenAI and venture capital firm Thrive Capital recently announced their support for Chai Discovery, a biology startup founded by former OpenAI and Meta researchers. Recently, the AI startup raised close to $30 million to develop AI models for drug discovery.
On September 9, the startup introduced Chai-1, an advanced AI model that can predict the structure of molecules, essential for drug discovery. The company…
Read the full article here